{"disease":{"id":"erythropoietic-protoporphyria","name":"Erythropoietic protoporphyria","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"afamelanotide","indication_name":"Erythropoietic protoporphyria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Scenesse","generic_name":"AFAMELANOTIDE","company_name":"Clivunel Inc","drug_phase":"marketed","molecular_target":"Melanocyte-stimulating hormone receptor","drug_class":"afamelanotide","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03520036","title":"Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Tanabe Pharma America, Inc.","has_results":true},{"nct_id":"NCT05308472","title":"Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Disc Medicine, Inc","has_results":true},{"nct_id":"NCT06388642","title":"Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Clinuvel Europe Limited","has_results":true},{"nct_id":"NCT05020184","title":"Effect of Oral Cimetidine in the Protoporphyrias","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Amy K. Dickey, M.D.","has_results":false},{"nct_id":"NCT04578496","title":"A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Clinuvel Pharmaceuticals Limited","has_results":true},{"nct_id":"NCT03682731","title":"Light Exposure Patterns and Symptoms Among Patients With Erythropoietic Protoporphyria","phase":"","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT05572125","title":"Iron Therapy in Erythropoietic Protoporphyria","phase":"","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}